InvestorsHub Logo
Followers 4
Posts 537
Boards Moderated 0
Alias Born 11/14/2012

Re: Gutter92 post# 31157

Friday, 12/28/2012 6:34:32 PM

Friday, December 28, 2012 6:34:32 PM

Post# of 130516
There's little chance big Pharma would buy a company with only a pre-clinical theraputic and even if they did, it would be for maybe $.25-.30. Pharma companies have resorted to buying molecules already FDA approved or at least post Phase I to improve their odds and lower their costs.